{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:30:04Z","timestamp":1790731804219,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"SVF Scientific and Professional Fund"},{"name":"Architect Finn Rahn\u2019s Legacy"},{"name":"Veterinarian Smidt\u2019s Foundation"},{"name":"IDEXX Laboratories"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Vet Scand"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13028-018-0357-9","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T12:21:35Z","timestamp":1516191695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Quantitative method for analysis of six anticoagulant rodenticides in faeces, applied in a case with repeated samples from a dog"],"prefix":"10.1186","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-2692","authenticated-orcid":false,"given":"Kristin Opdal","family":"Seljetun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Karinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Vindenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"357_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1017\/S0022172400045307","volume":"63","author":"FP Rowe","year":"1965","unstructured":"Rowe FP, Redfern R. Toxicity tests on suspected warfarin resistant house mice (Mus musculus L.). J Hyg. 1965;63:417\u201325.","journal-title":"J Hyg."},{"key":"357_CR2","unstructured":"Hadler MR, Buckle AP, editors. Forty five years of anticoagulant rodenticides\u2014past, present and future trends. In: Proceedings of the 15th vertebrate pest conference 1992: paper 36."},{"key":"357_CR3","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","volume":"119","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S\u201321S.","journal-title":"Chest"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2004.tb06407.x","volume":"181","author":"RI Baker","year":"2004","unstructured":"Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2004;181:492\u20137.","journal-title":"Med J Aust"},{"key":"357_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2141.1963.tb05475.x","volume":"9","author":"J Hellemans","year":"1963","unstructured":"Hellemans J, Vorlat M, Verstraete M. Survival time of prothrombin and factors vii, ix and x after completely synthesis blocking doses of coumarin derivatives. Br J Haematol. 1963;9:506\u201312.","journal-title":"Br J Haematol"},{"key":"357_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tvjl.2009.03.034","volume":"183","author":"P Berny","year":"2010","unstructured":"Berny P, Caloni F, Croubels S, Sachana M, Vandenbroucke V, Davanzo F, et al. Animal poisoning in Europe. Part 2: companion animals. Vet J. 2010;183:255\u20139.","journal-title":"Vet J."},{"key":"357_CR7","volume-title":"Annual report 2015","author":"Veterinary Poisons Information Service","year":"2016","unstructured":"Veterinary Poisons Information Service. Annual report 2015. London: Medical Toxicology and Information Services Ltd.; 2016."},{"key":"357_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.17236\/sat00011","volume":"157","author":"M Schediwy","year":"2015","unstructured":"Schediwy M, Mevissen M, Demuth D, Kupper J, Naegeli H. New causes of animal poisoning in Switzerland [in German]. Schweiz Arch Tierheilkd. 2015;157:147\u201352.","journal-title":"Schweiz Arch Tierheilkd"},{"key":"357_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ecoenv.2007.05.006","volume":"69","author":"M Martinez-Haro","year":"2008","unstructured":"Martinez-Haro M, Mateo R, Guitart R, Soler-Rodriguez F, Perez-Lopez M, Maria-Mojica P, et al. Relationship of the toxicity of pesticide formulations and their commercial restrictions with the frequency of animal poisonings. Ecotoxicol Environ Saf. 2008;69:396\u2013402.","journal-title":"Ecotoxicol Environ Saf"},{"key":"357_CR10","volume-title":"Prevalence of superwarfarins in dogs\u2014a survey of background levels in liver samples of autopsied dogs [in Norwegian]","author":"S Olerud","year":"2014","unstructured":"Olerud S, Pedersen J, Pettersen E. Prevalence of superwarfarins in dogs\u2014a survey of background levels in liver samples of autopsied dogs [in Norwegian]. Akershus: In depth study Norwegian University of Life Sciences (NMBU), Department of Companion Animal Clinical Sciences; 2014."},{"key":"357_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3109\/00498258809042269","volume":"18","author":"KR Huckle","year":"1988","unstructured":"Huckle KR, Hutson DH, Warburton PA. Elimination and accumulation of the rodenticide flocoumafen in rats following repeated oral administration. Xenobiotica. 1988;18:1465\u201379.","journal-title":"Xenobiotica"},{"key":"357_CR12","volume-title":"Directive 98\/8\/EC concerning the placing of biocidal products on the market. Bromadiolone. Product-type 14 (rodenticides)","author":"CIRCABC","year":"2010","unstructured":"CIRCABC. Directive 98\/8\/EC concerning the placing of biocidal products on the market. Bromadiolone. Product-type 14 (rodenticides). Sweden: Office for Official Publications of the European Communities; 2010."},{"key":"357_CR13","unstructured":"WHO. Anticoagulant rodenticides\u2014environmental health criteria 175. Geneva: International Programme on Chemical Safety, World Health Organization. 1995. http:\/\/www.inchem.org\/documents\/ehc\/ehc\/ehc175.htm . Accessed 13 July 2017."},{"key":"357_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000137881","volume":"27","author":"KA Bachmann","year":"1983","unstructured":"Bachmann KA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacology. 1983;27:281\u20138.","journal-title":"Pharmacology"},{"key":"357_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00139709-200524040-00005","volume":"24","author":"BE Watt","year":"2005","unstructured":"Watt BE, Proudfoot AT, Bradberry SM, Vale JA. Anticoagulant rodenticides. Toxicol Rev. 2005;24:259\u201369.","journal-title":"Toxicol Rev."},{"key":"357_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.envres.2010.07.009","volume":"110","author":"M Sage","year":"2010","unstructured":"Sage M, Fourel I, Coeurdassier M, Barrat J, Berny P, Giraudoux P. Determination of bromadiolone residues in fox faeces by LC\/ESI\u2013MS in relationship with toxicological data and clinical signs after repeated exposure. Environ Res. 2010;110:664\u201374.","journal-title":"Environ Res."},{"key":"357_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/nyas.13085","volume":"1374","author":"DL Feinstein","year":"2016","unstructured":"Feinstein DL, Akpa BS, Ayee MA, Boullerne AI, Braun D, Brodsky SV, et al. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci. 2016;1374:111\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"357_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.forsciint.2012.07.008","volume":"222","author":"H Yan","year":"2012","unstructured":"Yan H, Xiang P, Zhu L, Shen M. Determination of bromadiolone and brodifacoum in human blood using LC\u2013ESI\/MS\/MS and its application in four superwarfarin poisoning cases. Forensic Sci Int. 2012;222:313\u20137.","journal-title":"Forensic Sci Int"},{"key":"357_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1939-1676.1992.tb00981.x","volume":"6","author":"BJ Woody","year":"1992","unstructured":"Woody BJ, Murphy MJ, Ray AC, Green RA. Coagulopathic effects and therapy of brodifacoum toxicosis in dogs. J Vet Intern Med. 1992;6:23\u20138.","journal-title":"J Vet Intern Med"},{"key":"357_CR20","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"B Matuszewski","year":"2003","unstructured":"Matuszewski B, Constanzer M, Chavez-Eng C. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS. Anal Chem. 2003;75:3019\u201330.","journal-title":"Anal Chem"},{"key":"357_CR21","first-page":"219","volume":"23","author":"CT Eason","year":"1999","unstructured":"Eason CT, Milne L, Potts M, Morriss G, Wright GRG, Sutherland ORW. Secondary and tertiary poisoning risks associated with brodifacoum. NZ J Ecol. 1999;23:219\u201324.","journal-title":"NZ J Ecol."},{"key":"357_CR22","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1017\/S000711451100081X","volume":"106","author":"A Colyer","year":"2011","unstructured":"Colyer A, Gilham MS, Kamlage B, Rein D, Allaway D. Identification of intra-and inter-individual metabolite variation in plasma metabolite profiles of cats and dogs. Br J Nutr. 2011;106:S146\u20139.","journal-title":"Br J Nutr"},{"key":"357_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/0272-0590(90)90190-U","volume":"15","author":"MC Carakostas","year":"1990","unstructured":"Carakostas MC, Banerjee AK. Interpreting rodent clinical laboratory data in safety assessment studies: biological and analytical components of variation. Fundam Appl Toxicol. 1990;15:744\u201353.","journal-title":"Fundam Appl Toxicol"},{"key":"357_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1638\/1042-7260(2007)038[0217:SBVOCC]2.0.CO;2","volume":"38","author":"MF Bertelsen","year":"2007","unstructured":"Bertelsen MF, Kjelgaard-Hansen M, Howell JR, Crawshaw GJ. Short-term biological variation of clinical chemical values in Dumeril\u2019s monitors (Varanus dumerili). J Zoo Wildl Med. 2007;38:217\u201321.","journal-title":"J Zoo Wildl Med."},{"key":"357_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0034-5288(93)90003-X","volume":"54","author":"AL Jensen","year":"1993","unstructured":"Jensen AL, Aaes H. Critical differences of clinical chemical parameters in blood from dogs. Res Vet Sci. 1993;54:10\u20134.","journal-title":"Res Vet Sci"},{"key":"357_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1365-2036.2000.014s2002.x","volume":"14","author":"EA Shaffer","year":"2000","unstructured":"Shaffer EA. Control of gall-bladder motor function. Aliment Pharmacol Ther. 2000;14:2\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"357_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","volume":"41","author":"MS Roberts","year":"2002","unstructured":"Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation. Clin Pharmacokinet. 2002;41:751\u201390.","journal-title":"Clin Pharmacokinet"},{"key":"357_CR28","first-page":"323","volume-title":"The liver: biology and pathobiolology","author":"FR Simon","year":"2010","unstructured":"Simon FR. Hormonal regulation of bile secretion. In: Arias I, Alter HJ, Boyer JL, editors. The liver: biology and pathobiolology. New York: Wiley Blackwell; 2010. p. 323\u201339."},{"key":"357_CR29","first-page":"431","volume":"6","author":"G Parmar","year":"1987","unstructured":"Parmar G, Bratt H, Moore R, Batten P. Evidence from common binding site in vivo for the retention of anticoagulants in rat liver. Hum Toxicol. 1987;6:431\u20132.","journal-title":"Hum Toxicol."},{"key":"357_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2885.2008.00979.x","volume":"31","author":"V Vandenbroucke","year":"2008","unstructured":"Vandenbroucke V, Bousquet-Melou A, De Backer P, Croubels S. Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administration. J Vet Pharmacol Ther. 2008;31:437\u201345.","journal-title":"J Vet Pharmacol Ther"},{"key":"357_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/03014223.2012.746234","volume":"40","author":"M Crowell","year":"2013","unstructured":"Crowell M, Eason C, Hix S, Broome K, Fairweather A, Moltchanova E, et al. First generation anticoagulant rodenticide persistence in large mammals and implications for wildlife management. NZ J Zool. 2013;40:205\u201316.","journal-title":"NZ J Zool."},{"key":"357_CR32","volume-title":"Potential risks of nine rodenticides to birds and nontarget mammals: a comparative approach","author":"WA Erickson","year":"2004","unstructured":"Erickson WA, Urban DJ. Potential risks of nine rodenticides to birds and nontarget mammals: a comparative approach. Washington, DC: US Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances; 2004."},{"key":"357_CR33","unstructured":"Norwegian Environment Agency. List of authorised biocidal products in Norway. 2017. http:\/\/www.miljodirektoratet.no\/no\/Tema\/Kjemikalier\/Kjemikalieregelverk\/Biocider\/Biocidprodukter\/Godkjente-produkter-i-Norge\/ . Accessed 12 Mar 2017."},{"key":"357_CR34","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/ps.3809","volume":"70","author":"BG Meerburg","year":"2014","unstructured":"Meerburg BG, van Gent-Pelzer MP, Schoelitsz B, Esther A, van der Lee TA. Distribution of anticoagulant rodenticide resistance in Rattus norvegicus in the Netherlands according to Vkorc1 mutations. Pest Manag Sci. 2014;70:1761\u20136.","journal-title":"Pest Manag Sci"},{"key":"357_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ps.2254","volume":"68","author":"HJ Pelz","year":"2012","unstructured":"Pelz HJ, Rost S, Muller E, Esther A, Ulrich RG, Muller CR. Distribution and frequency of VKORC1 sequence variants conferring resistance to anticoagulants in Mus musculus. Pest Manag Sci. 2012;68:254\u20139.","journal-title":"Pest Manag Sci"},{"key":"357_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.scitotenv.2014.07.049","volume":"496","author":"A Geduhn","year":"2014","unstructured":"Geduhn A, Esther A, Schenke D, Mattes H, Jacob J. Spatial and temporal exposure patterns in non-target small mammals during brodifacoum rat control. Sci Total Environ. 2014;496:328\u201338.","journal-title":"Sci Total Environ"},{"key":"357_CR37","unstructured":"Fisher PM, Meiwen Z, Campion M, Pech R. Anticoagulant rodenticides in the environment: excretion as a residue transfer pathway. In: 17th Australasian vertebrate pest conference. Canberra, Australia; 2017."},{"key":"357_CR38","first-page":"883","volume":"86","author":"RG Watts","year":"1990","unstructured":"Watts RG, Castleberry RP, Sadowski JA. Accidental poisoning with a superwarfarin compound (brodifacoum) in a child. Pediatrics. 1990;86:883\u20137.","journal-title":"Pediatrics"},{"key":"357_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/00288233.1996.9513199","volume":"39","author":"C Eason","year":"1996","unstructured":"Eason C, Wright G, Batcheler D. Anticoagulant effects and the persistence of brodifacoum in possums (Trichosurus vulpecula). NZ J Agric Res. 1996;39:397\u2013400.","journal-title":"NZ J Agric Res."},{"key":"357_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/00288233.1985.10430438","volume":"28","author":"FJ Laas","year":"1985","unstructured":"Laas FJ, Forss DA, Godfrey MER. Retention of brodifacoum in sheep tissues and excretion in faeces. NZ J Agric Res. 1985;28:357\u20139.","journal-title":"NZ J Agric Res."},{"key":"357_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/01652176.1998.9694831","volume":"20","author":"JH Robben","year":"1998","unstructured":"Robben JH, Kuijpers EA, Mout HC. Plasma superwarfarin levels and vitamin K1 treatment in dogs with anticoagulant rodenticide poisoning. Vet Q. 1998;20:24\u20137.","journal-title":"Vet Q."},{"key":"357_CR42","unstructured":"Coumatetralyl. In: MacBean C, editor. The pesticide manual. 16th ed. London: British Crop Production Council; 2012. p. 238\u20139."},{"key":"357_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0269-7491(02)00297-X","volume":"122","author":"RF Shore","year":"2003","unstructured":"Shore RF, Birks JDS, Afsar A, Wienburg CL, Kitchener AC. Spatial and temporal analysis of second-generation anticoagulant rodenticide residues in polecats (Mustela putorius) from throughout their range in Britain, 1992\u20131999. Environ Pollut. 2003;122:183\u201393.","journal-title":"Environ Pollut."},{"key":"357_CR44","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.2193\/2005-615","volume":"71","author":"SPD Riley","year":"2007","unstructured":"Riley SPD, Bromley C, Poppenga RH, Uzal FA, Whited L, Sauvajot RM. Anticoagulant exposure and notoedric mange in bobcats and mountain lions in urban southern California. J Wildl Manage. 2007;71:1874\u201384.","journal-title":"J Wildl Manage."},{"key":"357_CR45","unstructured":"Kopanke JH, Horak KE, Musselman E, Bennett K, VandeWoude S, Bevins SE. Effects of low-level brodifacoum exposure on the feline immune response. In: 17th annual research day. Colorado State University\u2019s College of Veterinary Medicine and Biomedical Sciences; 2016."},{"key":"357_CR46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02843236","volume":"7","author":"S Yuanji","year":"1996","unstructured":"Yuanji S. Research on the control of forest rat using coumatetralyl. J Northeast For Univ. 1996;7:8\u201312.","journal-title":"J Northeast For Univ."},{"key":"357_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S0022172400061556","volume":"94","author":"G Chopra","year":"1985","unstructured":"Chopra G, Parshad VR. Evaluation of coumatetralyl against two predominant murid species. J Hyg. 1985;94:327\u201330.","journal-title":"J Hyg."},{"key":"357_CR48","first-page":"122","volume-title":"Vertebrate pesticide toxicology manual (poisons). Department of Conservation Technical Series 23","author":"CT Eason","year":"2001","unstructured":"Eason CT, Wickstrom ML. Vertebrate pesticide toxicology manual (poisons). Department of Conservation Technical Series 23. Wellington: Department of Conservations; 2001. p. 122."},{"key":"357_CR49","first-page":"155","volume-title":"Control of mammal pests","author":"YM Lam","year":"1987","unstructured":"Lam YM. Responses of three Malaysian rat species to regular intermittent feedings on first generation anticoagulant rodenticides. In: Richards CGJ, Ku TY, editors. Control of mammal pests. London: Taylor & Francis; 1987. p. 155\u201369."},{"key":"357_CR50","unstructured":"EU. Directive 98\/8\/EC concerning the placing biocidal products on the market. Assessment report: coumatetralyl. 2009."},{"key":"357_CR51","first-page":"1","volume-title":"Toxicological evaluation of the rodenticide coumatetralyl PM 931123","author":"National Chemicals Inspectorate","year":"1993","unstructured":"National Chemicals Inspectorate. Toxicological evaluation of the rodenticide coumatetralyl PM 931123. Solna: National Chemicals Inspectorate; 1993. p. 1\u201317."}],"container-title":["Acta Veterinaria Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-018-0357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T18:51:56Z","timestamp":1660330316000},"score":1,"resource":{"primary":{"URL":"https:\/\/actavetscand.biomedcentral.com\/articles\/10.1186\/s13028-018-0357-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1186\/s13028-018-0357-9","relation":{},"ISSN":["1751-0147"],"issn-type":[{"value":"1751-0147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"6 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}